Represents amount of accrued bonus to executive.

No definition available.

Name:	rttr_AccruedBonusToExecutive
Namespace Prefix:	rttr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	rttr_CommitmentsAndContingenciesLineItems
Namespace Prefix:	rttr_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents executive compensation payable upon satisfaction of condition.

+ References

No definition available.

+ Details

Name:	rttr_ExecutiveCompensation
Namespace Prefix:	rttr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents minimum actual deployment of funds by third party.

+ References

No definition available.

+ Details

Name:	rttr_MinimumActualDeploymentOfFundsByThirdParty
Namespace Prefix:	rttr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents number of share options vests ratably on a monthly basis.

+ References

No definition available.

+ Details

Name:	rttr_StockOptionsToVestRatablyOnMonthlyBasis
Namespace Prefix:	rttr_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_Cash
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Gross number of share options (or share units) granted during the period.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of exercisable share options (fully vested and expected to vest) that may be converted as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Percentage of vesting of share-based compensation awards.

+ References

+ Details

Name:	us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

+ Details

Name:	us-gaap_StockIssuedDuringPeriodValueNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	rttr_CashBonusAndExecutiveOptionsPerformanceConditionsAxis=rttr_FdaMeetingBonusOpportunitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=rttr_PresidentAndFormerChiefExecutiveOfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=rttr_ChiefStrategicOfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	rttr_CashBonusAndExecutiveOptionsPerformanceConditionsAxis=rttr_ClinicalTrialFundingCommitmentBonusOpportunitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	rttr_CashBonusAndExecutiveOptionsPerformanceConditionsAxis=rttr_FundraisingBonusOpportunitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	rttr_PerformanceMilestoneTypeAxis=rttr_PerformanceMilestoneConditionOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	rttr_PerformanceMilestoneTypeAxis=rttr_PerformanceMilestoneConditionTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

COMMITMENTS AND CONTINGENCIES (Detail Textuals 1) - USD ($)		1 Months Ended			3 Months Ended	6 Months Ended
	Dec. 02, 2014	Jun. 29, 2015	Apr. 30, 2013	Jul. 17, 2012	Jun. 30, 2015	Jun. 30, 2015	Jul. 31, 2015	Sep. 30, 2013	Sep. 25, 2013
Commitments And Contingencies [Line Items]
Granted						103,025
Initial Public Offering
Commitments And Contingencies [Line Items]
Net offering proceeds		$ 17,400,000
FDA Meeting Bonus Opportunities \| Andrew Ritter
Commitments And Contingencies [Line Items]
Cash bonus			$ 10,000
FDA Meeting Bonus Opportunities \| Ira Ritter
Commitments And Contingencies [Line Items]
Cash bonus			$ 10,000
Clinical Trial Funding Commitment Bonus Opportunities \| Andrew Ritter
Commitments And Contingencies [Line Items]
Cash bonus		75,000
Clinical Trial Funding Commitment Bonus Opportunities \| Ira Ritter
Commitments And Contingencies [Line Items]
Cash bonus		75,000
Clinical Trial Funding Commitment Bonus Opportunities \| General and administrative expense \| Andrew Ritter
Commitments And Contingencies [Line Items]
Accrued bonus to executive					$ 75,000	$ 75,000
Clinical Trial Funding Commitment Bonus Opportunities \| General and administrative expense \| Ira Ritter
Commitments And Contingencies [Line Items]
Accrued bonus to executive					75,000	75,000
Clinical Trial Funding Commitment Bonus Opportunities \| Minimum
Commitments And Contingencies [Line Items]
Minimum cash available limit		$ 2,000,000
Fundraising Bonus Opportunities \| General and administrative expense \| Andrew Ritter
Commitments And Contingencies [Line Items]
Accrued bonus to executive					150,000	150,000
Fundraising Bonus Opportunities \| General and administrative expense \| Ira Ritter
Commitments And Contingencies [Line Items]
Accrued bonus to executive					$ 150,000	$ 150,000
Fundraising Bonus Opportunities \| Performance milestone condition one
Commitments And Contingencies [Line Items]
Cash bonus				$ 50,000
Minimum actual deployment of funds by third party				2,000,000
Fundraising Bonus Opportunities \| Performance milestone condition one \| Minimum
Commitments And Contingencies [Line Items]
Minimum cash available limit				2,000,000
Fundraising Bonus Opportunities \| Performance milestone condition two
Commitments And Contingencies [Line Items]
Minimum actual deployment of funds by third party				10,000,000
Fundraising Bonus Opportunities \| Performance milestone condition two \| Andrew Ritter
Commitments And Contingencies [Line Items]
Cash bonus				150,000
Fundraising Bonus Opportunities \| Performance milestone condition two \| Ira Ritter
Commitments And Contingencies [Line Items]
Cash bonus				150,000
Fundraising Bonus Opportunities \| Performance milestone condition two \| Minimum
Commitments And Contingencies [Line Items]
Minimum cash available limit				$ 2,000,000
Executive Options \| Andrew Ritter
Commitments And Contingencies [Line Items]
Granted	453,413
Executive Options \| Ira Ritter
Commitments And Contingencies [Line Items]
Granted	453,413
Executive Options \| FDA Meeting Bonus Opportunities \| Andrew Ritter
Commitments And Contingencies [Line Items]
Number of stock options expected to vest								1,136	2,360
Executive Options \| FDA Meeting Bonus Opportunities \| Ira Ritter
Commitments And Contingencies [Line Items]
Number of stock options expected to vest								1,136	2,360
Executive Options \| Clinical Trial Funding Commitment Bonus Opportunities
Commitments And Contingencies [Line Items]
Stock options to vest ratably on a monthly basis		6,818
Percentage of option vest		35.00%
Granted		10,489
Vesting period of options		36 months
Executive Options \| Clinical Trial Funding Commitment Bonus Opportunities \| Andrew Ritter
Commitments And Contingencies [Line Items]
Number of stock options expected to vest		3,671
Executive Options \| Clinical Trial Funding Commitment Bonus Opportunities \| Ira Ritter
Commitments And Contingencies [Line Items]
Number of stock options expected to vest		3,671
Executive Options \| Fundraising Bonus Opportunities \| Initial Public Offering
Commitments And Contingencies [Line Items]
Net offering proceeds		$ 17,400,000
Executive Options \| Fundraising Bonus Opportunities \| Subsequent Event
Commitments And Contingencies [Line Items]
Number of stock options expected to vest							9,091
Executive Options \| Fundraising Bonus Opportunities \| Performance milestone condition one
Commitments And Contingencies [Line Items]
Percentage of option vest				35.00%
Granted				6,993
Maximum aggregate number of shares of common stock authorized to issue				6,993
Vesting period of options				36 months
Executive Options \| Fundraising Bonus Opportunities \| Performance milestone condition two
Commitments And Contingencies [Line Items]
Percentage of option vest				35.00%
Granted				13,986
Maximum aggregate number of shares of common stock authorized to issue				13,986
Vesting period of options				36 months
Executive Options \| Fundraising Bonus Opportunities \| Performance milestone condition two \| Andrew Ritter
Commitments And Contingencies [Line Items]
Number of stock options expected to vest		4,895
Executive Options \| Fundraising Bonus Opportunities \| Performance milestone condition two \| Ira Ritter
Commitments And Contingencies [Line Items]
Number of stock options expected to vest		4,895